We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Intermittent running: muscle metabolism in the heat and effect of hypohydration.
PURPOSE: This study reports two studies that investigated the reason for a poorer intermittent supramaximal running performance previously found in the heat (Maxwell et al., The effect of climatic heat stress on intermittent supramaximal running performance in humans. Exp. Physiol. 81:833-845, 1996). The first study tested the hypothesis that it was due to different rates of substrate metabolism. The second study tested whether a greater level of hypohydration led to an earlier exhaustion time.
METHODS: A maximal anaerobic running test (MART) was the exercise model used. This involved repeated 20-s runs, each at increasing intensities, with 100 s of passive recovery between runs.
RESULTS: In study 1, eight male subjects performed the MART on two occasions at either 32.8+/-0.3 degrees C, 80.5+/-1.6% relative humidity (RH), or 21.3+/-0.4 degrees C, 48.8+/-2.2% RH. Needle biopsy samples were taken from the vastus lateralis muscle before and immediately after the MART. In study 2, 11 male subjects performed the MART in a moderately hypohydrated (HYPO) and euhydrated (EUH) state while in a cool environment. In study 1, performance was significantly worse in the hot compared with the cool environment (138+/-7 vs. 150+/-6 s, respectively, P<0.05). No differences were observed in the change in muscle glycogen (100.3+/-15.1 vs. 107.0+/-15.6 mmol glucosyl units x kg dry muscle(-1)) or muscle lactate (102.9+/-18.2 vs. 100.5+/-16.6 mmol x kg dry muscle(-1)) between the hot and cool environments, respectively. In study 2, performance was worse in the HYPO (148+/-9 s) compared with the EUH (154+/-9 s) trial (P<0.05).
CONCLUSIONS: These results indicate that a reduced intermittent supramaximal running performance in the heat is not caused by greater muscle glycogenolysis or lactate accumulation. Further, a poorer intermittent sprinting performance is experienced in a hypohydrated compared with a euhydrated state.
METHODS: A maximal anaerobic running test (MART) was the exercise model used. This involved repeated 20-s runs, each at increasing intensities, with 100 s of passive recovery between runs.
RESULTS: In study 1, eight male subjects performed the MART on two occasions at either 32.8+/-0.3 degrees C, 80.5+/-1.6% relative humidity (RH), or 21.3+/-0.4 degrees C, 48.8+/-2.2% RH. Needle biopsy samples were taken from the vastus lateralis muscle before and immediately after the MART. In study 2, 11 male subjects performed the MART in a moderately hypohydrated (HYPO) and euhydrated (EUH) state while in a cool environment. In study 1, performance was significantly worse in the hot compared with the cool environment (138+/-7 vs. 150+/-6 s, respectively, P<0.05). No differences were observed in the change in muscle glycogen (100.3+/-15.1 vs. 107.0+/-15.6 mmol glucosyl units x kg dry muscle(-1)) or muscle lactate (102.9+/-18.2 vs. 100.5+/-16.6 mmol x kg dry muscle(-1)) between the hot and cool environments, respectively. In study 2, performance was worse in the HYPO (148+/-9 s) compared with the EUH (154+/-9 s) trial (P<0.05).
CONCLUSIONS: These results indicate that a reduced intermittent supramaximal running performance in the heat is not caused by greater muscle glycogenolysis or lactate accumulation. Further, a poorer intermittent sprinting performance is experienced in a hypohydrated compared with a euhydrated state.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app